🚀 Announcing the launch of Phase 2 of the Biomarkers of Aging Challenge Series: Mortality Prediction! Phase 2 focuses on identifying and benchmarking the most promising predictors of mortality, aiming to advance our understanding and validation of aging biomarkers. This Phase will run until November 1, 2024. ☠️ Why Mortality Prediction? Mortality is a crucial outcome for aging biomarkers due to its clear and binary nature. Both first-generation biomarkers and newer models trained specifically to predict time to death have shown significant promise in predicting mortality and age-related diseases. Phase 2 benchmarks predictors of mortality to identify the current limits of accuracy and prediction, while also harnessing this potential to provide valuable insights and foster innovation in mortality prediction. 💰 Prize: $70,000 USD in rewards 👉 Join Phase 2: synapse.org/biomarkers 👈 🏆About The Biomarkers of Aging Challenge Series: Systematic benchmarking and validation of aging biomarkers are essential for their use in clinical research and longevity interventions. However, limited access to high-quality omics datasets and disparate biomarker implementations present significant challenges. The Biomarkers of Aging Consortium addresses these issues by hosting a series of challenges designed to drive innovation and collaboration. 🎯 Challenge Objectives: Our Challenge spans three phases, with the goal of identifying and benchmarking the best predictors of chronological age, mortality, and multi-morbidity. We aim to discover cutting-edge biomarkers that can reliably predict aging-related outcomes, supporting ongoing technology development and enabling large-scale longitudinal studies. 🙏 Many thanks to our partners for their support of the Challenge including: @mfoundation @AlamarBio @xprize Healthspan @Sagebio @CompetitionSci @VoLoFoundation 🩷 We also want to thank all the fantastic competitors who have participated in our Challenge so far and those who will join us in this phase and beyond. Your dedication and innovative spirit are driving the future of longevity research. 🙌 Together, we can drive the future of biomarkers of aging, unlocking a better understanding of the aging process and making significant strides towards extending healthy human lifespan: synapse.org/biomarkers

📅 Join us this Friday, March 1st at 12 p.m. ET / 9 a.m. PT for the Biomarkers of Aging Challenge Series kick-off in our X Spaces, co-hosted by @DaneGobel of @mfoundation and @j_n_justice from @xprize #XPRIZEHealthspan 🙌 We're excited to welcome Consortium members @mahdi_moqri, @jpoganik, @chiara_herzog, @Sarudak and @allisondman, alongside partners Josh Neubert from @CompetitionSci and Luca Foschini from @Sagebio as speakers. 🏆 Our Biomarkers Challenge focuses on uniting a diverse community passionate about extending healthy human lifespan, including biomarker developers, data scientists, and longevity enthusiasts. Le everything about the Challenge, its critical role in establishing reliable biomarkers of aging for longevity interventions, collaborations with our partners, ways to participate and WIN! Plus, we'll have an open Q&A session, so bring your questions! 👇 Sign up for our X Spaces and add the event to your calendar by scanning our QR code. Or use this link: bit.ly/join-our-challenge-xs… Join us! CC @VoLoFoundation, @BuckInstitute, @hevolution_f, @quadrascope @OpenCuresOrg, @vita_dao, @foresightinst, @OlinkProteomics, @foxo_tech, @AlamarBio, @bioagelabs, @GeroSense, @PhaedonInstitut, @LongevityTech, @LongevityGL, @LifespanIO, @gladyshev_lab, @SnyderShot, @SebastianoLab, @AndreaBMaier, @EricVerdin, @NirBarzilaiMD, and all the amazing mission-aligned organizations and people out there 🩷

We're kicking off our Biomarkers of Aging Challenge on March 1st with @mfoundation's @DaneGobel and @j_n_justice from @xprize #XPRIZEHealthspan in our first ever X Spaces to discuss how our Challenge will support the development and validation of next-gen biomarkers of aging for longevity interventions! Join us!👇